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Background:	Dried	 Bloodspots	 (DBS)	 are	 used	 for	 the	 analysis	 of	 >2000	 biomarkers.	 We	
assessed	a	range	of	analyte	concentrations	and	diameters	of	DBS	created	by	the	application	
of	 increasing	 volumes	 of	 whole	 blood	 prepared	 by	 the	 UK	 NEQAS	 Quality	 Assurance	
Laboratory.	 Samples	were	analysed	 in	 four	 separate	 laboratories.	Results:	Volumes	<25µL	
(8mm)	 and	 >75µL	 (14mm)	 created	 unsatisfactory	 analytical	 biases.	 Results	 obtained	 from	
peripheral	 sub-punches	 tended	 to	 be	 higher	 than	 those	 from	 a	 central	 sub-punch.	
Conclusion:	DBS	diameters	formed	from	non-volumetric	application	of	blood	to	filter	paper	
can	be	used	to	assess	whether	measurement	bias	will	be	within	acceptable	limits	according	





Guthrie	and	Susi	 showed	 the	applicability	of	dried	blood	 spot	 (DBS)	 sampling	 to	newborn	
screening	(NBS)	in	1963,	Guthrie	having	developed	a	method	for	blood	spot	phenylalanine	a	
few	years	earlier	[1].	However,	recent	advances	in	analytical	technologies	have	led	to	more	
than	2000	biomarkers	being	analysed	 in	DBS	samples	 [2].	DBS	samples	are	an	 increasingly	
attractive	sample	type	for	use	in	healthcare	surveillance	due	to	their	relative	stability,	small	
blood	 volumes	 required	 and	 ease	 of	 transport	 from	 remote	 sites	 for	 analysis.	 Analysis	 of	
DBS	 samples	 is	 employed	 routinely	 for	 therapeutic	 drug	 and	 treatment	 monitoring,	
toxicological	analyses	and	therapy	adjustment	in	patients	with	inherited	disorders	[2-5].		
The	 process	 of	 DBS	 specimen	 collection	 typically	 involves	 the	 application	 of	 a	 non-
volumetric	amount	of	blood	(single	hanging	drop	of	blood)	from	a	heel	or	finger	prick	that	
disperses	by	both	 spreading	 radially	across	 the	 filter	paper,	whilst	penetrating	 the	porous	
fibres	to	 fully	soak	through	the	filter	paper.	 Ideally,	 the	distribution	of	analytes	across	the	
filter	paper	 collection	device	 should	be	 constant.	However,	 the	plasma	component	of	 the	
blood	applied	occupies	a	greater	fractional	volume	of	the	interior	of	the	filter	paper	fibres	
than	 the	 erythrocytes	 and	 as	 a	 result	 the	 erythrocytes	 concentrate	 at	 the	 edge	 of	 the	
bloodspot	 (which	 is	 often	 visible).	 This	 loss	 of	 homogeneity	 across	 the	 DBS,	 results	 in	




a	 fixed	 diameter)	 of	 a	 defined	 volume	 can	 be	 obtained	 from	 a	 DBS	 formed	 from	 a	 non-




no	 direct	method	 to	 detect	 Hct	 in	 DBS	 samples.	Whilst	 non-destructive	methods	 for	 Hct	
prediction	and	thus	concentration	correction	have	been	developed,	these	have	not	yet	been	
conveniently	incorporated	into	available	punching	equipment	[13].	The	results	obtained	by	
analysis	of	DBS	 samples	are	 therefore	 inherently	 less	precise	 than	 those	obtained	using	a	
	 3	
fixed	 volume	 of	 liquid	 whole	 blood.	 It	 is	 therefore	 important	 to	 understand	 and	 control	
where	possible	any	pre-analytical	variables	that	may	affect	the	final	test	result.	
	
Filter	 paper	 collection	 devices	 usually	 have	 printed	 broken	 line	 circles	 of	 a	 predefined	
diameter	 to	 serve	as	a	guide	 for	 specimen	collectors	 to	obtain	appropriate	sized	samples.	
The	quality	of	DBS	specimens	received	into	the	NBS	laboratory	are	assessed	subjectively	by	
visual	 inspection;	ensuring	 that	 the	printed	circle	 is	 suitably	 filled	with	blood,	 the	blood	 is	
spread	 symmetrically	 and	 evenly	 with	 blood	 viewed	 from	 both	 sides	 of	 the	 filter	 paper.	
Repeat	samples	are	requested	on	those	samples	deemed	unsuitable	for	analysis.	In	the	UK,	
the	filter	paper	collection	devices	used	for	NBS	have	four	printed	guide	circles	with	an	inner	
diameter	 of	 10mm,	 which	 when	 appropriately	 filled	 contain	 approximately	 35-50µL	 of	
whole	blood.	Currently,	 in	 the	UK	a	minimum	spot	diameter	of	7mm	 is	 recommended	 for	
NBS,	as	this	provides	two	3.2mm	sub-punches	[14].	However,	 it	should	be	highlighted	that	
the	diameter	of	 the	 calibrator,	 quality	 control	 and	external	quality	 assessment	 (EQA)	DBS	
samples	 used	 in	 different	 jurisdictions	 internationally	 vary	 significantly.	 Furthermore,	 the	








four	 separate	NBS	 laboratories	 and	 to	 assess	 the	utility	 of	 using	 the	diameter	 of	 the	DBS	
sample	 received	 by	 the	 testing	 laboratory	 as	 a	 guide	 for	 the	 rejection	 of	 inappropriately	
sized	 DBS	 samples.	 The	 blood	 absorption	 matrix	 utilised,	 PerkinElmer	 226,	 is	 used	 for	
newborn	 screening	 in	 all	 four	 UK	 countries	 and	many	 other	 jurisdictions	 globally.	 Due	 to	






DBS	 samples	were	 prepared	 as	 follows;	 a	 fresh	 donor	 unit	 of	 packed	 red	 cells,	 in	 citrate	
phosphate	 dextrose	 (CPD)	 anticoagulant	 (containing	 anhydrous	 glucose	 129.0	 mmol/L;	
sodium	 citrate	 89.4	 mmol/L;	 citric	 acid	 monohydrate	 15.6	 mmol/L;	 sodium	 dihydrogen	
phosphate	 dihydrate	 16.1	mmol/L)	 was	 obtained	 from	 the	 National	 Health	 Service	 Blood	
and	 Transplant	 Service	 (NHSBT,	 Colindale,	 UK).	 The	 collection	 and	 storage	 of	 packed	 red	





measuring	 the	 plasma	 and	 erythrocyte	 lengths	 in	 the	 tube	 using	 a	 ruler.	 The	 UK	 NEQAS	
Quality	Laboratory	(Birmingham,	UK)	routinely	use	blood	products	sourced	from	NHSBT	to	
prepare	 DBS	 EQA	 material	 that	 is	 supplied	 to	 all	 UK	 newborn	 screening	 laboratories	 to	
assess	performance.	
	
The	 whole	 blood	 was	 enriched	 with	 thyroid	 stimulating	 hormone	 [TSH,	 10	 mU/L],	
immunoreactive	 trypsin	 [IRT,	 20µg/L],	 phenylalanine	 [Phe	 240µmol/L],	 tyrosine	 [Tyr	
240µmol/L],	 octanoyl	 carnitine	 [C8,	 0.5µmol/L],	 decanoyl	 carnitine	 [C10,	 0.5µmol/L],	
Isovalerylcarnitine	 [C5,	 1.1µmol/L],	 glutarylcarnitine	 [C5DC,	 0.7µmol/L],	 leucine	 [Leu,	
600µmol/L],	 and	 methionine	 [Met,	 50	 µmol/L].	 Phenylalanine,	 Tyrosine,	 Leucine	 and	
Methionine	 were	 obtained	 from	 Sigma-Aldrich	 Company	 Ltd,	 Gillingham,	 Dorset,	 UK.	 C5,	
C5DC,	 C8	 and	 C10	 were	 obtained	 from	 Cambridge	 Isotope	 Laboratories,	 Andover,	 MA	
01810,	 USA.	 TSH	 was	 obtained	 from	 SciPak,	 Sittingbourne,	 UK	 and	 trypsin	 was	 obtained	
from	 Athens	 Research	 &	 Technology,	 Athens,	 GA,	 USA.	 Analytes	 were	 dissolved	 in	 0.9%	
saline,	with	acidification	where	necessary.	The	volume	of	 the	non	matrix	material	used	 to	
enrich	 the	 sample	 was	 <1%	 of	 the	 total	 blood	 volume.	 Following	 enrichment,	 the	 blood	











group.	 Therefore	 a	 total	 of	 1080	 bloodspots	 were	 prepared	 for	 each	 laboratory.	 The	
samples	 were	 allowed	 to	 air	 dry	 at	 ambient	 temperature	 before	 shipment	 at	 ambient	
temperature	via	a	courier	 service	 to	 the	 four	newborn	screening	 laboratories	 for	analysis.	
Samples	were	stored	at	ambient	temperature	until	analysis.	Samples	were	analysed	within	
14	days	of	receipt	into	the	laboratories.	It	is	known	that	metabolites	can	degrade	over	time.	





Thirty	 replicates	 each	 of	 central	 (C)	 and	 peripheral	 (P)	 punches	 (3.2mm)	 (Figure	 1)	 were	
analysed	 for	 every	 bloodspot	 volume	 for	 TSH,	 IRT,	 amino	 acids	 and	 the	 acylcarnitines.	
Samples	 were	 analysed	 in	 four	 UK	 NBS	 Laboratories	 (Cardiff,	 Leeds,	 Manchester	 and	
Sheffield)	 to	 assess	 consistency	 of	 analysis.	 For	 the	 analysis	 of	 TSH	 and	 IRT	 commercially	
available	 (PerkinElmer,	 Finland)	 dissociation	 enhanced	 fluorimetric	 immunoassays	 were	
used	 (these	are	 routinely	used	 in	all	 the	UK	newborn	screening	 laboratories).	 Samples	 for	
TSH	and	IRT	analysis	were	prepared	for	analysis	as	per	the	manufacturer’s	instructions.	For	
the	analysis	of	 the	amino	acids	and	acylcarnitine	species,	 samples	were	punched	 (3.2mm)	
into	 96	 well	 plates	 and	 methanol	 containing	 the	 internal	 standards	 (Cambridge	 Isotope	
Laboratories)	was	added	to	each	well	as	the	extraction	solvent.	The	plates	were	covered	and	
shaken	for	20	minutes	on	a	plate	shaker,	the	eluent	was	then	analysed	using	tandem	mass	
spectrometry	 (MS/MS)	 using	 a	mobile	 phase	 containing	 acetonitrile,	 deionised	water	 and	
	 6	








averages	 calculated	 for	 each	 volume.	 Finally	 the	measurements	 from	each	observer	were	
averaged	at	each	volume.	
	
The	 relationship	between	 the	DBS	diameters	 and	blood	drop	 volume	applied	 to	 the	 filter	
paper	collection	devices	was	examined	in	three	ways:		









the	 filter	paper	collection	device	 [20].	No	attempt	was	made	 in	 this	study	to	measure	the	
thickness	across	each	dried	spot	or	the	thickness	of	cards	before	the	application	of	blood	as	
such	 technology	 is	 not	 available	 in	 the	 UK	 Newborn	 Screening	 Laboratories.	 Using	 the	
cylinder	 model	 the	 thickness	 was	 back	 calculated	 for	 each	 drop	 volume	 using	 Python™	
software.	 Additionally	 the	 least	 squares	 method	 was	 used	 in	 Python	 for	 50	 possible	
thicknesses	 from	 0.40	 to	 0.60	 mm	 in	 0.004	 increments	 in	 order	 to	 select	 the	 best	 fit	
theoretical	thickness	for	this	lot	number	of	collection	devices.	





3. A	 broken	 stick	 model	 (segmented	 linear	 regression)	 comparing	 the	 volume	 of	 blood	





thickness	of	 filter	paper	 (0.52mm),	d1d2	=	observed	diameter	 (minimum	and	maximum	




Statistical	 analysis	 was	 carried	 out	 using	 one-way	 ANOVA	 with	 post-hoc	 Tukey	 test,	
calculated	 using	 SPSS	 (v16).	 All	 statistical	 analysis	 was	 carried	 out	 on	 the	 analyte	
concentrations	and	not	on	percentage	differences.	Bloodspot	diameter/dispersion	statistical	
analysis	 utilised	 a	 non-parametric	 Kruskal-Wallis	 rank	 sum	 test	 with	 post	 hoc	 analysis.	 P	
values	<0.05	were	considered	as	 indicating	 statistical	 significance.	To	overcome	any	 inter-
laboratory	biases	and	any	potential	sample	degradation	effects	as	a	result	of	the	differences	
between	 the	 timing	 of	 sample	 receipt	 and	 analysis,	 we	 calculated	 and	 analysed	 the	
percentage	bias	differences	 for	each	of	 the	volumes	 (central	 and	peripheral	 sub-punches)	
compared	to	the	concentration	in	a	50µL	central	spot	analysed	in	each	of	the	laboratories.	
The	results	from	a	central	punch	from	a	50µL	bloodspot	was	used	as	the	standard	control	
value	 for	 comparison	as	 this	 volume	 fills	 the	10	mm	printed	circle	on	 the	UK	NBS	card.	A	












7.4%	 respectively.	 DBS	 samples	 with	 volumes	 ≥75µL	 produced	 significantly	 higher	 results	
than	 the	 50µL	 central	 sub-punch	 results	 for	 most	 analytes.	 The	 mean	 positive	 biases	
observed	 for	 the	 analytes	 (excluding	 IRT)	 in	 the	 50µL	 peripheral,	 75µL	 central,	 75µL	
peripheral,	 100µL	 central	 and	 100µL	 peripheral	 punches	 vs	 the	 50µL	 central	 punch	were	







those	 obtained	 from	 a	 central	 punch	 (Table	 1).	 This	 study	 is	 consistent	 with	 previously	
published	 studies	 which	 have	 also	 shown	 that	 results	 obtained	 using	 peripheral	 punch	
locations	 are	 often	 higher	 than	 those	 from	 a	 central	 punch	 location	 [10-12].	 This	 was	
statistically	significant	at	all	volumes	for	TSH,	for	all	except	the	10µL	volume	for	C8	and	C10,	
for	 four	 of	 the	 six	 volumes	 for	 IRT	 and	 C5	 and	 three	 of	 the	 six	 volumes	 for	 leucine	 and	
phenylalanine.	 Only	 for	 tyrosine,	 methionine	 and	 C5DC	 did	 the	 difference	 not	 reach	















The	 thin	 cylinder	 hypothesis	 permitted	 the	 formulation	 of	 curves	which	 varied	 slightly	 in	
best	 curve	 fit	 according	 to	 the	 apparent	 thickness	 of	 the	 filter	 paper.	 The	 calculated	
thickness	 of	 the	 filter	 paper	 at	 the	 volumes	 of	 10µL,	 25µL,	 35µL,	 50µL,	 75µL	 and	 100µL	
volume	bloodspots	were;	0.354,	0.451,	0.474,	0.450,	0.501	and	0.468	mm	respectively.	The	
least	 best	 fit	 was	 for	 the	 10µL	 sample,	 with	 a	 0.354	 mm	 calculated	 thickness.	 The	 filter	
paper	thickness	with	the	best	overall	fit	to	the	measured	diameter	versus	volume	from	the	
mathematical	 testing	 of	 50	 different	 filter	 paper	 thicknesses	 was	 0.465	 mm.	 The	 mean	
thickness	excluding	the	10µl	sample	was	0.469mm.	
	
The	 thin	 cylinder	 equation	 describing	 the	 relationship	 between	 DBS	 diameter	 and	 blood	
volume	applied	derived	from	first	principles	here	differs	from	that	of	Hall	and	colleagues	[8],	















10µL	 (Figure	 4).	 The	 variability	 of	 dispersion	 of	 blood	 onto	 the	 filter	 paper	 at	 10µL	 was	
significantly	greater	than	the	dispersion	at	all	other	volumes	(P<0.001	for	25,	35,	50,	75	and	
100µL;	 P<0.01	 for	 50	µL).	Dispersion	 at	 volumes	≥25	µL	 appears	 to	be	 relatively	 constant	
(Figure	4).	Although	it	has	been	shown	that	the	diameter	of	a	DBS	sample	is	related	to	the	
total	 volume	 and	 Hct	 of	 blood	 applied	 [8],	 the	 Hct	 was	 kept	 constant	 during	 this	 study.	
However,	the	speed	of	sample	dispensing	has	been	shown	to	affect	DBS	diameters	[22],	and	





The	 DBS	 samples	 produced	 for	 this	 study	 were	 prepared	 by	 UK	 NEQAS	 from	 washed,	
anticoagulated,	 donor	 red	 blood	 cells	 and	 fresh	 frozen	 plasma,	 applied	manually	 to	 filter	
paper	using	pipettes.	This	is	significantly	different	to	the	processes	used	to	collect	newborn	
heel	prick	 samples	and	 to	 collect	 samples	 for	other	healthcare	and	 surveillance	purposes.	
However,	some	of	the	findings	in	this	study	compare	to	routine	NBS	test	results	e.g.	higher	
results	 observed	 in	 peripheral	 vs	 central	 punches.	 There	 may	 have	 been	 variation	 in	
peripheral	 punch	 location	 between	 laboratories	 i.e.	 how	 far	 from	 the	 edge	was	 the	 sub-
punch	 taken	as	 this	may	have	affected	 the	differences	 in	analyte	concentrations	between	
the	sub-punches.	Imaging	software	may	have	provided	more	accurate	mean	diameters	than	
using	 callipers.	 The	 thickness	 of	 the	 filter	 paper	 was	 not	 measured	 before	 or	 after	 the	





Our	 results	 confirm	 previous	 findings	 that	 compared	 to	 a	 50µL	 sample	 volume	 smaller	
volume	DBS	samples	produce	lower	analyte	concentrations	and	that	results	obtained	from	
peripheral	punch	locations	are	higher	than	those	from	a	central	punch	location.	In	addition,	
those	 samples	 with	 larger	 volumes	 applied	 to	 filter	 paper	 produce	 significantly	 higher	
results.	A	similar	type	of	work	has	been	carried	out	previously,	using	the	range	of	analytes	
that	 are	 included	 in	 the	 UK	 NBS	 Programme	 [11,	 12].	 However,	 no	 study	 to	 date	 has	
assessed	 these	 various	 factors	 utilising	 EQA	 material	 and	 analysed	 in	 multiple	 testing	
laboratories.	The	results	from	this	study	validate	previous	findings	and	provide	reassurance	
that	 blood	 used	 in	 DBS	 EQA	material	 for	 NBS	 behaves	 in	 a	manner	 that	 is	 analogous	 to	




Filter	 paper	 collection	devices	 for	 capillary	 blood	 collection	 from	heel	 or	 finger	 pricks	 are	
Class	 II	 Medical	 Devices	 and	 should	 ideally	 meet	 agreed	 international	 criteria	 for	
performance	such	as	those	by	the	Clinical	&	Laboratory	Standards	 Institute.	Filter	paper	 is	
produced	 from	cotton	 linters,	and	defines	how	the	matrix	 influences	blood	collection	and	














To	maximise	 the	 accuracy	 of	 the	 results,	 DBS	 samples	 should	 be	 the	 same	 diameter	 and	
punched	in	the	same	location	as	the	calibrator	material	/	EQA	material.	UK	NEQAS	produce	
DBS	 samples	 by	 the	 application	 of	 35µL	 volumes	 of	 whole	 blood	 at	 an	 Hct	 of	 55%.	 This	
volume	almost	 fills	 the	10	mm	printed	circle	used	 in	the	UK.	UK	NEQAS	recommends	that	
sub-punches	are	taken	from	the	centre	of	DBS	EQA	material.	Conversely,	DBS	diameters	of	
calibration	materials	 provided	by	 the	CDC	are	much	 larger	 (15	 -	 18mm)	derived	 from	 the	
application	of	sample	volumes	≥75µL	of	enriched	blood	(now	at	a	50%	Hct,	formerly	55%).	
DBS	 material	 provided	 by	 PerkinElmer	 for	 the	 calibration	 of	 the	 TSH	 and	 IRT	 assays	 are	
usually	larger	than	10	mm	(12mm	for	IRT	and	15mm	for	TSH)	in	diameter,	which	could	affect	
the	accuracy	of	results	in	newborn	DBS	samples	that	differ	significantly	in	volume	of	blood	
applied	 compared	 to	 the	 calibration	 DBS	 samples.	 Furthermore,	 assay	 performance	 on	 a	
patient’s	results	cannot	be	assessed	objectively	if	the	patient’s	bloodspots	differ	in	size	and	
Hct	from	those	in	EQA	specimens.	In	addition,	some	of	the	materials	are	prepared	by	using	
lysed	 blood	 and	 not	 whole	 blood	 which	 may	 have	 different	 effects	 in	 terms	 of	 sample	
homogeneity	and	diameter.		
	
Smaller	 blood	 volumes	 applied	 to	 filter	 paper	 produce	 analytical	 results	 with	 significant	
negative	 biases	 for	 many	 analytes	 especially	 at	 volumes	 <25µL,	 which	 corresponds	 to	 a	
diameter	<8mm	[11,	12].	A	negative	bias	due	to	the	use	of	small	samples	for	analysis	may	
risk	 failing	 to	 detect	 a	 disorder	 from	 the	 current	 panel	 of	 disorders,	 which	 infants	 are	








of	all	 samples	>7mm	diameter	 [14].	Our	study	 indicates	 that	consideration	should	also	be	




where	 the	 results	 in	 affected	 infants	may	 be	 near	 to	 the	 screening	 cut-offs	 (e.g.	 TSH	 for	




pose	 issues	 in	 the	 future	 if	 the	 aim	 is	 to	 identify	 analyte	 results	 below	 an	 action	 value	
instead,	 for	 example,	 low	 T-receptor	 excision	 circles	 (TRECs)	 for	 severe	 combined	
immunodeficiency	 (SCID)	 screening	 and	 enzyme	 activities	 for	 the	 screening	 of	
galactosaemia,	biotinidase	deficiency	and	lysosomal	storage	disorders.	Improvement	in	DBS	
specimen	 size	 and	 quality	 could	 be	 potentially	 achieved	 by	 the	 use	 of	 blood	 collection	





punches	 taken	 from	 different	 locations	 within	 the	 DBS	 produce	 significantly	 different	
analytical	results.	These	differences	are	not	 just	theoretical	but	can	impact	significantly	on	
patient	pathways	when	absolute	analyte	values	are	used	in	screening	or	diagnostic	testing	
algorithms.	 Furthermore,	 understanding	 and	 controlling	 for	 the	pre-analytical	 factors	 that	





are	 enriched	 with	 the	 various	 analytes.	 Previous	 studies	 have	 never	 been	 undertaken	 in	









DBS	 specimen	 size	 and	 quality	 can	 significantly	 affect	 an	 analytical	 result,	 which	 has	
implications	 for	 the	 use	 of	DBS	 not	 only	 for	 population	 screening,	 but	 also	 diagnosis	 and	
monitoring.	Findings	 from	our	study	can	be	utilised	 to	ensure	 that	 the	appropriate	size	of	
samples	 are	 accepted	 for	DBS	assays,	 thereby	ensuring	 the	 correct	outcome	 for	 the	baby	
being	screened	and	 to	 standardise	practice	by	ensuring	 that	all	 laboratories	are	accepting	
and	 rejecting	 samples	of	 the	 same	 size	and	quality.	 Future	work	 is	 required	 to	assess	 the	
accuracy	and	homogeneity	of	the	use	of	calibrator	and	QC	materials	prepared	using	lysates.	
The	development	of	high	 throughput	 scanning	 technology	 to	 routinely	assess	DBS	 sample	












































Analyte	 	 10µL	 25µL	 35µL	 50µL	 75µL	 100µL	
Phenylalanine	 C	 259	(30)	 287	(34)	 284	(31)	 294	(32)	 313	(38)	 326	(37)	
P	 267	(32)	 300	(39)	 299	(40)	 311	(45)‡	 323	(48)‡	 348	(56)*	
Tyrosine	 C	 196	(28)	 230	(33)	 220	(31)	 226	(35)	 236	(34)	 254	(33)	
P	 209	(27)	 239	(35)	 228	(35)	 238	(38)	 248	(41)	 261	(47)	
Methionine	 C	 30.0	(2.3)	 33.0	(2.6)	 32.3	(2.7)	 34.4	(2.8)	 34.5	(2.9)	 35.9	(3.7)	
P	 30.2	(2.7)	 33.6	(2.9)	 32.6	(2.9)	 35.1	(2.8)	 34.9	(3.0)	 36.4	(3.6)	
Leucine		 C	 575	(62)	 652	(72)	 634	(59)	 652	(64)	 693	(78)	 731	(74)	
P	 595	(71)	 677	(80)	 662	(81)	 692	(97)*	 721	(104)‡	 771	(123)‡	
C5	 C	 0.80	(0.11)	 0.93	(0.10)	 0.90	(0.11)	 0.92	(0.12)	 1.01	(0.11)	 1.06	(0.11)	
P	 0.84	(0.10)	 0.97	(0.10)	 0.95	(0.11)‡	 0.98	(0.11)*	 1.06	(0.11)‡	 1.13	(0.12)*	
C5DC	 C	 0.51	(0.15)	 0.60	(0.16)	 0.60	(0.15)	 0.62	(0.16)	 0.68	(0.16)	 0.72	(0.17)	
P	 0.56	(0.13)	 0.64	(0.17)	 0.64	(0.14)	 0.66	(0.16)	 0.69	(0.17)	 0.74	(0.19)	
C8	 C	 0.50	(0.04)	 0.56	(0.04)	 0.55	(0.04)	 0.57	(0.05)	 0.60	(0.04)	 0.64	(0.05)	
P	 0.52	(0.05)	 0.59	(0.05)*	 0.59	(0.05)*	 0.61	(0.05)*	 0.65	(0.05)*	 0.69	(0.06)*	
C10	 C	 0.61	(0.06)	 0.68	(0.06)	 0.65	(0.05)	 0.65	(0.05)	 0.68	(0.05)	 0.71	(0.05)	
P	 0.63	(0.04)	 0.70	(0.04)‡	 0.69	(0.06)*	 0.71	(0.07)*	 0.75	(0.07)*	 0.79	(0.09)*	
TSH	 C	 8.2	(0.51)	 9.3	(0.62)	 9.03	(0.68)	 8.7	(0.73)	 9.2	(0.80)	 9.5	(0.62)	
P	 8.9	(0.64)*	 10.1(0.85)*	 10.1	(0.89)*	 9.9	(1.07)*	 10.3	(0.86)*	 10.9	(1.4)*	
IRT	 C	 21.7	(2.3)	 24.3	(2.9)	 22.9	(2.5)	 20.8	(2.6)	 21.9	(2.8)	 23.3	(2.8)	







Effect	 of	 sample	 volume	 on	 DBS	 diameter.	 The	 printed	 circle	 (dashed	 line)	 diameter	 is	













(n=60	 samples	per	 volume).	Vs	=	2∏t.d1d2/4,	where	 t	 =	 assumed	 thickness	of	 filter	paper	



























7 Cobb	 Z,	 de	 Vries	 R,	 Spooner	 N	 et	 al.	 In-depth	 study	 of	 homogeneity	 in	 DBS	 using	 two	













10 Holub	M,	Tuschl	K,	Ratschmann	R,	et	al.	 Influence	of	haematocrit	and	 localisation	of	
punch	 in	dried	blood	 spots	on	 levels	of	 amino	acids	 and	acylcarnitines	measured	by	
tandem	mass	spectrometry.	Clin.	Chim.	Acta.	373,	27-31	(2006).	
	










13 Capiau	S,	Wilk	L,	De	Kesel	P,	et	al.	Correction	for	 the	Hematocrit	Bias	 in	Dried	Blood	















17 Jopling	 J,	Henry	 E,	Weidmeier	 SE,	 Christensen	RD.	Reference	 ranges	 for	haematocrit	

























25 Spooner	N,	Denniff	P,	Michielsen	 L,	et	al.	A	device	 for	dried	blood	microsampling	 in	








27 Leuthold	 L,	 Heudi	 O,	Déglon	 J	 et	 al.
	




28 Velghe	 S,	 Delahaye	 L,	 Stove	 C.	 Is	 the	 hematocrit	 still	 an	 issue	 in	 quantitative	 dried	
blood	spotanalysis?	J.	Pharm	&	Biomed	Anal.	163,	188-196	(2019).	
	
	
	
